AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
VBK.DE

Verbio SE (VBK.DE) fair value

Basic Materials · Specialty Chemicals · XETRA · Germany
€28.48+1.79%
Market cap €1.8BNext earnings 2026-11-12Updated Oct 22, 2026
Add earnings to calendarGoogle
Our verdict
Trades 37% below our fair value
Price
€28.48
Model fair valueConfidence: low
about €45.00
Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Treated as a cyclical company. None of the usual models had enough data, so this uses Analyst consensus instead.
ACCE opinionVerbio SE (VBK.DE)
Fair value
Not available
ACCE price target
€31.00
Rating
Not rated
Horizon
12 months
ACCE price target published on 23 Oct 2026, 01:52 CEST.
Price used: €28.48 at the close on 23 Oct 2026, 17:30 CEST.
Models: Analyst consensus.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
56
out of 100
P/E
27.9x
forward 11.0x
1-year return
+88.9%
Dividend yield
0.00%

Verbio SE in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Verbio SE makes renewable fuels in Germany: bioethanol and biomethane from grain and by-products, plus biodiesel and renewable fuel for the German and EU transport markets, which is where the company sells most of its volume. The structural case rests on EU and German biofuel mandates and quota rules that create captive demand for advanced biofuels, rather than on the company's chemical peers, which it only loosely resembles despite its industry tag. Revenue growth of 22.7% and an operating margin of 11.7% point to a business still scaling into those mandates, but an 8.2% ROE and an 18.0% gross margin show how thin the economics remain. The valuation looks inconsistent on its face: a trailing P/E of 27.4 against a forward P/E of 10.8 implies a sharp expected earnings recovery that the trailing numbers do not yet show, so the gap is the first thing to test. Worth a deeper look to establish whether 2025 and 2026 earnings are rebounding on policy-supported margins or whether the forward figure rests on assumptions that the current margin structure cannot yet carry.

AI-assisted·How I use AIWritten Oct 23, 2026

Next results

Nov 12, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where VBK.DE's valuation models land
Price
€28.48
Model fair valueConfidence: low
about €45.00
Model
Fair value
Upside
Analyst consensus
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
-4.6%
1 month
-10.4%
3 months
-11.8%
6 months
-26.4%
YTD
+34.3%
1 year
+88.9%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:52 CESTACCE price target€31.00first publication€27.98

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in EUR. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full VBK.DE page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth64Value58Quality56Momentum46Total56
Valuation
Trailing P/E
27.9x
Forward P/E
11.0x
PEG
4.81
P/B
2.64x
EV / Revenue
1.2x
Book value/sh
€12.76
Enterprise value
€2.2B
Profitability
ROE
8.2%
FCF yield
no data
ROIC
5.0%
Health and risk
Debt / equity
0.27
Dividend yield
0.00%
Beta
0.06

Price

+83.0% · 1Y

Ask anything about VBK.DE

Answered from Verbio SE fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 17% of peers
low 12.0x27.9xhigh 50.1x
ROEbetter than 60% of peers
low 5%8%high 21%
Div yieldbetter than 17% of peers
low 0.0%0.0%high 5.0%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
VBK.DE Verbio SE€28.48--27.9x8.2%5656
4208.T UBE Corporation¥3248.00--13.2x5.6%4866
ALPEKA.MX AlpekMXN 15.54MXN 2228% below50.1x5.1%3867
4043.T Tokuyama Corporation¥3761.00--12.0x-3962
5301.T Tokai Carbon Co., Ltd.¥1874.00--21.4x6.8%5267
8012.T Nagase & Co., Ltd.¥1178.00--12.5x9.6%4871
ENAEX.SN Enaex S.ACLP 24589.00--15.7x21.0%6566

Sector report card

Where VBK.DE ranks against its sector peers on each metric.

Computing percentiles…